Wellgistics Health receives extension to cure stockholders equity deficiency
Wellgistics Health received a deficiency notice from Nasdaq on April 13, 2026 after reporting stockholders equity of $(12,447,801) as of December 31, 2025, below the $2,500,000 minimum required under Nasdaq Listing Rule 5550(b)(1). On June 9, 2026, Nasdaq granted the company an extension until October 12, 2026 to regain compliance, contingent on furnishing either a completed transaction demonstrating the equity requirement has been satisfied or a pro forma balance sheet showing compliance. The company is pursuing a merger with DataVault AI and acquisition of assets from Tollo Health, estimating post-transaction stockholders equity of approximately $40 million. Separately, the company regained compliance with Nasdaq's minimum bid price requirement on June 9, 2026.
Key facts
- Stockholders equity of $(12,447,801) as of December 31, 2025
- Nasdaq Listing Rule 5550(b)(1) minimum stockholders equity requirement: $2,500,000
- Compliance deadline: October 12, 2026
- Estimated post-transaction stockholders equity: approximately $40 million
- Deficiency notice received: April 13, 2026
- Extension granted: June 9, 2026
- Minimum bid price requirement regained compliance: June 9, 2026
Why it matters
Wellgistics must execute its planned merger with DataVault AI and Tollo Health acquisition by the October 12 deadline to avoid a delisting determination; failure to evidence compliance by year-end 2026 will trigger delisting proceedings.
Developing story
- NT 10-Q
- 8-Kthis filing
Share
Get the next chapter in your inbox — a Sentinel watches this company and briefs the next material filing the moment it lands.
Derived from 8-K filed 2026-06-12. Not investment advice. View the source filing on SEC.gov →